Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jia-xing ZHAN"'
Autor:
Si-hui YU, Zhao-meng SHAN, Jing-jing YANG, Yi-ning LIU, Chang-de WU, Zhen-jiang ZHANG, Yuan-mao ZHU, Bo MENG, Jia-xing ZHAN, Xue-xia WEN, Ying ZHANG
Publikováno v:
Journal of Integrative Agriculture, Vol 22, Iss 6, Pp 1945-1949 (2023)
Externí odkaz:
https://doaj.org/article/4d72149febb44c46bfd76ce372e67a60
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 3, Pp n/a-n/a (2024)
Abstract The cardiovascular (CV) safety of febuxostat compared to allopurinol for the treatment of hyperuricemia among Asian patients is uncertain. In this study, we conducted a systematic review and meta‐analysis to compare the CV safety profiles
Externí odkaz:
https://doaj.org/article/17c3a386654e4db8b0b9b439910e7b55
Autor:
Hai-chao Liu, Yun-bo Yang, Peng Zhang, Jia-xing Zhang, Zhi-sheng Pei, Bo-wen Chen, Gui-qian Liu, Hui Li
Publikováno v:
Italian Journal of Pediatrics, Vol 49, Iss 1, Pp 1-6 (2023)
Abstract Background To investigate the efficacy and safety of endoscopic electrocoagulation haemostasis via a percutaneous transhepatic approach for the treatment of grade IV haemorrhagic cystitis (HC) after allogeneic haematopoietic stem cell transp
Externí odkaz:
https://doaj.org/article/479bd71adef9416daf7fc16559bbcf56
Autor:
Jing-Wen Ma, Xu Jiang, Yan-Mei Wang, Jiu-Ming Jiang, Lei Miao, Lin-Lin Qi, Jia-Xing Zhang, Xin Wen, Jian-Wei Li, Meng Li, Li Zhang
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24372- (2024)
Objectives: Patients with epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma (LUAD) can benefit from individualized targeted therapy. This study aims to develop, compare, analyse prediction models based on dual-energy spectral c
Externí odkaz:
https://doaj.org/article/9314850a66344a57b2a9fe6f0060c682
Autor:
Tian-yue Liu, Chen-chen Hu, Chen-ying Han, Si-yi Mao, Wen-xin Zhang, Yi-ming Xu, Yuan-jie Sun, Dong-bo Jiang, Xi-yang Zhang, Jia-xing Zhang, Jing Wang, Xu-peng Qiao, Jing-yu Pan, Shu-ya Yang, Kun Yang
Publikováno v:
Biology Direct, Vol 18, Iss 1, Pp 1-13 (2023)
Abstract Background Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive system, ranking third for morbidity and mortality worldwide. At present, no effective control method is available for this cancer type. In tumor c
Externí odkaz:
https://doaj.org/article/fcf3e94848c44d49a9b1560ab72c4967
Autor:
Jia-Xing Zhang, Wen Li, Xiu-Juan Tao, Chen Chen, Qing-An Wang, Wan-Lu Liu, Chan Yang, Kai-Rong Wang, Jiang-Wei Qiu, Yi Zhao, Yu-Hong Zhang
Publikováno v:
Lipids in Health and Disease, Vol 21, Iss 1, Pp 1-11 (2022)
Abstract Background Although dyslipidaemia may have a crucial impact on cardiovascular health in adults, there is a lack of specific data in transitional-age youth. Therefore, this study attempted to evaluate the association of dyslipidaemia with fat
Externí odkaz:
https://doaj.org/article/42aeef1f231244adaa290343d2b57a92
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Thyroid tumors, one of the common tumors in the endocrine system, while the discrimination between benign and malignant thyroid tumors remains insufficient. The aim of this study is to construct a diagnostic model of benign and malignant thyroid tumo
Externí odkaz:
https://doaj.org/article/edbc059ec0de4a029e04bc967b8c980b
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesThis study aimed to evaluate and summarize the contrast-enhanced computed tomography (CECT) imaging features of micronodular thymoma with lymphoid stroma (MTWLS) based on all MTWLS patients at our institution and was the first imaging study
Externí odkaz:
https://doaj.org/article/a9265891302d4d1483af1092b0df30c6
Autor:
Jia-Xing Zhang, Yi Xu, Ying Gao, Cui Chen, Zhou-San Zheng, Miao Yun, Hui-Wen Weng, Dan Xie, Sheng Ye
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-1 (2022)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0586-y.
Externí odkaz:
https://doaj.org/article/88b54086c7144ca69147dde4ee0dcfe1
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundOnly a proportion of patients with bladder cancer may benefit from durable response to immune checkpoint inhibitor (ICI) therapy. More precise indicators of response to immunotherapy are warranted. Our study aimed to construct a more precis
Externí odkaz:
https://doaj.org/article/1b559ccb71774e748902c3f8d65e22db